Alba Brandes

16PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 26, 2023
Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial.

Tobias Kessler, Daniel Schrimpf, Laura Doerner

|Jan 31, 2023
Glioblastoma treatment slowly moves toward change: novel druggable targets and translational horizons in 2022.

Lidia Gatto, Enrico Franceschi, Alicia Tosoni

|Dec 28, 2022
How to treat histone 3 altered gliomas: molecular landscape and therapeutic developments.

Vincenzo Di Nunno, Enrico Franceschi, Lidia Gatto

|Jul 20, 2022
Corticosteroids use and neurocognitive functioning in patients with recurrent glioblastoma: Evidence from European Organization for Research and Treatment of Cancer (EORTC) trial 26101.

Ivan Caramanna, Julie M de Kort, Alba A Brandes

|Apr 09, 2022
Pharmacotherapeutic Treatment of Glioblastoma: Where Are We to Date?

Lidia Gatto, Vincenzo Di Nunno, Enrico Franceschi

|Dec 01, 2021
BET inhibitors: the promise of a new generation of immunotherapy in glioblastoma.

Vincenzo Di Nunno, Enrico Franceschi, Lidia Gatto

Pageof 3

Frequent Collaborators

11 joint publications

Enrico Franceschi

10 joint publications

Vincenzo Di Nunno

3 joint publications

Wolfgang Wick

2 joint publications

Raffaele Lodi